Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

NCT02607423 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped The study failed to meet its accrual targets.

Conditions

Stage IIIA Non-Small Cell Lung Cancer

Interventions

DRUG: Cisplatin
PROCEDURE: Computed Tomography
DRUG: Docetaxel
RADIATION: Fludeoxyglucose F-18
DRUG: Gemcitabine Hydrochloride
DRUG: Pemetrexed Disodium
PROCEDURE: Positron Emission Tomography

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]